Cargando…
Upcoming treatments for morphea
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a female predominance. Insights into morphe...
Autores principales: | Wenzel, Dan, Haddadi, Nazgol‐Sadat, Afshari, Khashayar, Richmond, Jillian M., Rashighi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589364/ https://www.ncbi.nlm.nih.gov/pubmed/34272836 http://dx.doi.org/10.1002/iid3.475 |
Ejemplares similares
-
Telemedicine and the battle for health equity: Translating temporary regulatory orders into sustained policy change
por: Kassamali, Bina, et al.
Publicado: (2020) -
Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus–Like Inflammation
por: Haddadi, Nazgol-Sadat, et al.
Publicado: (2022) -
Controversy around the morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2021) -
Morphea and Eosinophilic Fasciitis: An Update
por: Mertens, Jorre S., et al.
Publicado: (2017) -
Morphea – selected local treatment methods and their effectiveness
por: Narbutt, Joanna, et al.
Publicado: (2017)